Company intelligence / Profile preview
Chongqing Lummy Pharmaceutical
Chongqing, Chongqing, Chinacqlummy.com ↗
- Ownership
- Private
- Employees
- ~1019
- Development stage
- Other
01
Overview
Chongqing Lummy Pharmaceutical develops and manufactures a broad range of pharmaceutical products with strengths in injectables. It has approved drugs for tuberculosis using bacterial replacement therapies and multiple oncology assets in early clinical development. The company also works on cell therapies such as TCR-T cell therapy and therapeutic vaccines targeting cancer. Its pipeline covers anti-tumor agents, anti-infectives including antibiotics that have passed drug consistency evaluation recently, cardiovascular drugs, endocrine/metabolic agents, antifungals, opioid receptor antagonists among others.
- Therapeutic areas
- Infectious DiseasesGastroenterologyEndocrinologyOncologyImmunology
- Modalities
- Small moleculeCell therapyTCR-T cell therapyTherapeutic vaccineChemical drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Strategic collaboration with Novoprotein/Cunde for mRNA solid tumor research announced December 2023.
Beyond the preview
Go deeper on Chongqing Lummy Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chongqing Lummy Pharmaceutical.